Analysis of the Therapeutic Monoclonal Antibodies Market in Europe

Exploring the Use of Biologics to Control Rising Disease Incidences

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The research service aims to analyse and assess the Therapeutic Monoclonal Antibodies market in Europe. This is performed by analysing the key trends and dynamics shaping the industry sector in correlation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and an immense rise in the rate of disease incidences, the use of monoclonal antibodies for therapeutics has been on the increase. The tendency towards biologics has been on the increase during the past decade. This research service provides an in-depth knowledge of the key European markets by presenting significant growth opportunities for the existing drugs and those in the pipeline until 2016.

Table of Contents

Analysis of the Therapeutic Monoclonal Antibodies Market in Europe, Executive SummarySnapshot of the Therapeutic Monoclonal Antibodies MarketSummaryAnalysis of the Therapeutic Monoclonal Antibodies Market in Europe, Market OverviewOverview of the Therapeutic Monoclonal AntibodiesOverviewAnalysis of the Therapeutic Monoclonal Antibodies Market in Europe, External Challenges: Drivers and Restraints—Monoclonal Antibodies MarketOverview of the Market Drivers and RestraintsAnalysis of the Market Drivers and RestraintsAnalysis of the Therapeutic Monoclonal Antibodies Market in Europe, Forecasts and Trends—Monoclonal Antibodies MarketOverview of the Revenue Forecasts and TrendsAnalysis of the Market Forecasts and TrendsAnalysis of the Therapeutic Monoclonal Antibodies Market in Europe, Market Share and Competitive Analysis: Monoclonal Antibodies MarketOverview of the Market Share and Competitive AnalysisAnalysis of the Market Share and Competitive AnalysisAnalysis of the Therapeutic Monoclonal Antibodies Market in Europe, Segmentation by TherapeuticsSegmentation Based on the Area of TherapyPer cent of Revenue by Segment OncologyAutoimmune and InflammatoryInfectiousOthersRegional Analysis of the Monoclonal Antibodies MarketAnalysis Based on GeographyGermanyFranceThe United KingdomSpainItalyBenelux ScandinaviaAnalysis of the Therapeutic Monoclonal Antibodies Market in Europe, The Last WordConclusionThe Last WordLegal DisclaimerAnalysis of the Therapeutic Monoclonal Antibodies Market in Europe, AppendixSupport Data TablesMarket Engineering MethodologyTable of Acronyms UsedDatabase of Key Industry ParticipantsDecision Support Database




Keyword1

Keyword2

Keyword3

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.